HiFiBiO Therapeutics: Pioneering Curative Immunotherapies


Liang Schweizer, Founder, Chairperson and CEO of HiFiBiO Therapeutics, sits down with Nasdaq Host, Kristina Ayanian, to discuss how the company's single-cell analytics platform is designed to mobilize the human immune system to combat cancer and autoimmune disorders.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now